ATOS
#4601
Atossa Therapeutics, Inc. - Common Stock
2.4 4 USD
+0.08%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+7.96%
Changement Mensuel
+10.41%
Evolution sur 6 mois
+269.70%
Changement Annuel
+168.13%
Clôture Précédente
2.2 6
Open
2.4 4
Low
2.4 4
High
2.4 4
Volume
4
Financials
- Market Capitalization 21.01 M
- Employee 14
- Founded 2008
- CEO Steven C. Quay
- Website www.atossatherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002NCD8C8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4584 |  KZIA Kazia Therapeutics Limited - American Depositary Shares | 13.44 USD | -0.22% | +2.60% | -1.90% | +129.74% | 21.76 M USD | ||
| 4592 |  SKYE Skye Bioscience, Inc. - Common Stock | 0.61 USD | -1.61% | -14.08% | -16.44% | -23.75% | 21.44 M USD | ||
| 4603 |  CLRB Cellectar Biosciences, Inc. - Common Stock | 2.61 USD | -0.76% | -6.79% | +6.10% | -16.88% | 20.86 M USD | ||
| 4614 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 4.78 USD | -4.78% | -17.01% | -49.95% | +288.62% | 20.02 M USD |